MyMD Pharmaceuticals Inc

Company Profile

MyMD Pharmaceuticals Inc had its IPO on 2014-01-23 under the ticker symbol MYMD.

The company operates in the Healthcare sector and Biotechnology industry. MyMD Pharmaceuticals Inc has a staff strength of 9 employees.

Stock update

Shares of MyMD Pharmaceuticals Inc opened at $0.73 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $0.65 - $0.73, and closed at $0.7.

This is a -3.95% slip from the previous day's closing price.

A total volume of 565,933 shares were traded at the close of the day’s session.

In the last one week, shares of MyMD Pharmaceuticals Inc have slipped by -21.3%.

MyMD Pharmaceuticals Inc's Key Ratios

MyMD Pharmaceuticals Inc has a market cap of $40.01 million, indicating a price to book ratio of 3.0825 and a price to sales ratio of 0.

In the last 12-months MyMD Pharmaceuticals Inc’s revenue was $0 with a gross profit of $0 and an EBITDA of $-28182912. The EBITDA ratio measures MyMD Pharmaceuticals Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, MyMD Pharmaceuticals Inc’s operating margin was 0% while its return on assets stood at -42.58% with a return of equity of -94.99%.

In Q2, MyMD Pharmaceuticals Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

MyMD Pharmaceuticals Inc’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $-0.32 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into MyMD Pharmaceuticals Inc’s profitability.

MyMD Pharmaceuticals Inc stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of -3.3322. Its price to sales ratio in the trailing 12-months stood at 0.

MyMD Pharmaceuticals Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$25.25 million

Total Liabilities

$2.43 million

Operating Cash Flow

$3.83 million

Capital Expenditure

$0

Dividend Payout Ratio

0%

MyMD Pharmaceuticals Inc ended 2024 with $25.25 million in total assets and $0 in total liabilities. Its intangible assets were valued at $25.25 million while shareholder equity stood at $10.74 million.

MyMD Pharmaceuticals Inc ended 2024 with $3.47 million in deferred long-term liabilities, $2.43 million in other current liabilities, 110567664.00 in common stock, $-99970418.00 in retained earnings and $10.50 million in goodwill. Its cash balance stood at $93823.00 and cash and short-term investments were $11.63 million. The company’s total short-term debt was $70,287 while long-term debt stood at $0.

MyMD Pharmaceuticals Inc’s total current assets stands at $13.14 million while long-term investments were $1.50 million and short-term investments were $11.53 million. Its net receivables were $0 compared to accounts payable of $1.66 million and inventory worth $0.

In 2024, MyMD Pharmaceuticals Inc's operating cash flow was $3.83 million while its capital expenditure stood at $0.

Comparatively, MyMD Pharmaceuticals Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$0.7

52-Week High

$3.69

52-Week Low

$0.65

Analyst Target Price

$

MyMD Pharmaceuticals Inc stock is currently trading at $0.7 per share. It touched a 52-week high of $3.69 and a 52-week low of $3.69. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $1.13 and 200-day moving average was $1.6 The short ratio stood at 2.36 indicating a short percent outstanding of 0%.

Around 1725.4% of the company’s stock are held by insiders while 1074.8% are held by institutions.